These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6717373)

  • 1. Rifampicin-induced suppression of antitumor immunity.
    Roszkowski W; Lipinska R; Roszkowski K; Jeljaszewicz J; Pulverer G
    Med Microbiol Immunol; 1984; 172(4):197-205. PubMed ID: 6717373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific immune response against tumor-associated antigens of a syngeneic simian virus 40-induced sarcoma in mice.
    Glaser M
    J Natl Cancer Inst; 1978 Nov; 61(5):1351-5. PubMed ID: 213615
    [No Abstract]   [Full Text] [Related]  

  • 3. Effector phenotypes and mechanisms of antitumor immune reactivity of tumor-immunized and tumor-bearing mice in two syngeneic tumors.
    Fuyama S; Komatsu H; Arai S
    Cell Immunol; 1991 Oct; 137(1):200-15. PubMed ID: 1679379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
    Hanna N; Schneider M
    J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of 12 antibiotics on antitumor immunity in BALB/c-mice.
    Roszkowski K; Beuth J; Ko HL; Roszkowski W; Jeljaszewicz J; Pulverer G
    Zentralbl Bakteriol; 1992 Jan; 276(2):280-7. PubMed ID: 1559013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human prolactin improves antitumor effects of murine natural killer cells in vitro and in vivo.
    Sun R; Wei H; Zhang J; Li A; Zhang W; Tian Z
    Neuroimmunomodulation; 2002-2003; 10(3):169-76. PubMed ID: 12481157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocompetence of splenocytes from mice bearing different-aged tumors assessed in lymphocyte-induced angiogenesis assay.
    Kamiński MJ; Janik P; Kamińska G
    Neoplasma; 1980; 27(4):363-6. PubMed ID: 6161315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of levamisole on methylcholanthrene-induced tumor. I. Its antitumor effect and immunological mechanism].
    Gomi K; Morimoto M; Nomoto K
    Gan To Kagaku Ryoho; 1982 Jul; 9(7):1262-8. PubMed ID: 7184454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein bound polysaccharide PSK abrogates more efficiently experimental metastases derived from H-2 negative than from H-2 positive fibrosarcoma tumor clones.
    Algarra I; Collado A; Garrido F
    J Exp Clin Cancer Res; 1997 Dec; 16(4):373-80. PubMed ID: 9505208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melphalan-induced enhancement of antitumor immune reactivity in thymocytes of adult BALB/c mice bearing a large MOPC-315 tumor.
    Bartik MM; Takesue BY; Mokyr MB
    Cancer Res; 1987 Sep; 47(18):4848-55. PubMed ID: 3497711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different responses of lymphoid cells from tumor-bearing as compared to tumor-immunized mice when sensitized to tumor specific antigens in vitro.
    Kall MA; Hellström I; Hellström KE
    Proc Natl Acad Sci U S A; 1975 Dec; 72(12):5086-9. PubMed ID: 1082135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective T helper activity in the spleen of BALB/c mice immune to a syngeneic fibrosarcoma.
    Grazioli L; Sensi M; Parmiani G
    Cancer Immunol Immunother; 1987; 24(3):237-43. PubMed ID: 2954636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some characteristics of the cyclophosphamide-induced immunopotentiating cells in the spleen of mice bearing a large MOPC-315 tumor.
    Mokyr MB; Ye QW
    Cancer Res; 1985 Oct; 45(10):4932-9. PubMed ID: 4027979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of immunogenic tumors to elicit cytolytic T cells in syngeneic hosts.
    Nelson DS; Hopper KE; Blanden RV; Gardner ID; Kearney R
    Cancer Lett; 1978 Aug; 5(2):61-7. PubMed ID: 308390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell-mediated antitumor immune response induced by oncofetal antigens.
    Gautam S; Deodhar SD
    J Natl Cancer Inst; 1981 Oct; 67(4):939-45. PubMed ID: 6974275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Induction of activated natural killer cells by the streptococcal preparation OK432 (I). Induction from spleen cells of normal or tumor-bearing mouse primed in vivo and subsequently challenged in vitro with OK432].
    Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K
    Nihon Gan Chiryo Gakkai Shi; 1989 Jul; 24(7):1370-8. PubMed ID: 2809371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells.
    Paciucci PA; Macphail S; Bach FH; Zarling JM
    J Immunol; 1980 Jul; 125(1):36-9. PubMed ID: 6155401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysis of fresh natural killer-resistant tumor cells by lectin-activated syngeneic and allogeneic murine splenocytes.
    Mazumder A; Rosenstein M; Rosenberg SA
    Cancer Res; 1983 Dec; 43(12 Pt 1):5729-34. PubMed ID: 6640524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant tumor necrosis factor alpha inhibits growth of methylcholanthrene-induced sarcoma and enhances natural killer activity of tumor-infiltrating lymphocytes in aging rats.
    Ziółkowska M; Nowak JJ; Janiak M; Ryzewska A
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):357-64. PubMed ID: 8010877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.